Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Burrows

Showing results (111-120 of 152) with videos related to

Pageof 16
Sort By:
Metabolic Brain Disease|March 7, 2012
Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitisGregory G Burrows, Roberto Meza-Romero, Jianya Huan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Regulation of encephalitogenic T cells with recombinant TCR ligandsG G Burrows, K L Adlard, B F Bebo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 27, 2009
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligandSushmita Sinha, Sandhya Subramanian, Lisa Miller, et al.
Stroke|May 16, 2009
Recombinant T cell receptor ligand treats experimental strokeSandhya Subramanian, Bing Zhang, Yasuharu Kosaka, et al.
European Journal of Immunology|March 23, 2006
Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium diseaseAndrew P Fontenot, David M Edwards, Yuan K Chou, et al.
Acta Psychiatrica Scandinavica|November 1, 1994
The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophreniaN Keks, J McGrath, T Lambert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosisYuan K Chou, David M Edwards, Andrew D Weinberg, et al.
European Journal of Immunology|April 12, 2013
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effectsGil Benedek, Roberto Meza-Romero, Shayne Andrew, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activationChunhe Wang, Jeffery L Mooney, Roberto Meza-Romero, et al.
QJM : Monthly Journal of the Association of Physicians|March 12, 2005
Survival among hospital in-patients with troponin T elevation below levels defining myocardial infarctionG Cook, D Taylor, M France, et al.
Pageof 16

Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Metabolic Brain Disease|March 7, 2012
Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitisGregory G Burrows, Roberto Meza-Romero, Jianya Huan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Regulation of encephalitogenic T cells with recombinant TCR ligandsG G Burrows, K L Adlard, B F Bebo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 27, 2009
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligandSushmita Sinha, Sandhya Subramanian, Lisa Miller, et al.
Stroke|May 16, 2009
Recombinant T cell receptor ligand treats experimental strokeSandhya Subramanian, Bing Zhang, Yasuharu Kosaka, et al.
European Journal of Immunology|March 23, 2006
Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium diseaseAndrew P Fontenot, David M Edwards, Yuan K Chou, et al.
Acta Psychiatrica Scandinavica|November 1, 1994
The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophreniaN Keks, J McGrath, T Lambert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosisYuan K Chou, David M Edwards, Andrew D Weinberg, et al.
European Journal of Immunology|April 12, 2013
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effectsGil Benedek, Roberto Meza-Romero, Shayne Andrew, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activationChunhe Wang, Jeffery L Mooney, Roberto Meza-Romero, et al.
QJM : Monthly Journal of the Association of Physicians|March 12, 2005
Survival among hospital in-patients with troponin T elevation below levels defining myocardial infarctionG Cook, D Taylor, M France, et al.
Pageof 16